These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26619923)

  • 1. Characteristics and Outcomes of HEDIS-Defined Asthma Patients with COPD Diagnostic Coding.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
    J Allergy Clin Immunol Pract; 2016; 4(2):273-83.e5. PubMed ID: 26619923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
    J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
    Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
    J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Eosinophil Count and Outcomes in Severe Uncontrolled Asthma: A Prospective Study.
    Zeiger RS; Schatz M; Dalal AA; Chen W; Sadikova E; Suruki RY; Kawatkar AA; Qian L
    J Allergy Clin Immunol Pract; 2017; 5(1):144-153.e8. PubMed ID: 27665383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
    J Allergy Clin Immunol Pract; 2017; 5(4):1050-1060.e9. PubMed ID: 28215604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
    Yun JH; Lamb A; Chase R; Singh D; Parker MM; Saferali A; Vestbo J; Tal-Singer R; Castaldi PJ; Silverman EK; Hersh CP;
    J Allergy Clin Immunol; 2018 Jun; 141(6):2037-2047.e10. PubMed ID: 29709670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of exacerbations and blood eosinophils in UK and US COPD populations.
    Vogelmeier CF; Kostikas K; Fang J; Tian H; Jones B; Morgan CL; Fogel R; Gutzwiller FS; Cao H
    Respir Res; 2019 Aug; 20(1):178. PubMed ID: 31391053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of disease associated with a COPD eosinophilic phenotype.
    Ortega H; Llanos JP; Lafeuille MH; Germain G; Duh MS; Bell CF; Sama SR; Hahn B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2425-2433. PubMed ID: 30147308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
    Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
    COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada.
    Poder TG; Carrier N; Bélanger M; Couillard S; Courteau J; Larivée P; Vanasse A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3065-3076. PubMed ID: 30349220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood eosinophil count variability in chronic obstructive pulmonary disease and severe asthma.
    Abe Y; Suzuki M; Kimura H; Shimizu K; Takei N; Oguma A; Matsumoto-Sasaki M; Goudarzi H; Makita H; Nishimura M; Konno S
    Allergol Int; 2023 Jul; 72(3):402-410. PubMed ID: 36586746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.
    Price DB; Rigazio A; Campbell JD; Bleecker ER; Corrigan CJ; Thomas M; Wenzel SE; Wilson AM; Small MB; Gopalan G; Ashton VL; Burden A; Hillyer EV; Kerkhof M; Pavord ID
    Lancet Respir Med; 2015 Nov; 3(11):849-58. PubMed ID: 26493938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype.
    Hirai K; Shirai T; Suzuki M; Akamatsu T; Suzuki T; Hayashi I; Yamamoto A; Akita T; Morita S; Asada K; Tsuji D; Inoue K; Itoh K
    Clin Exp Allergy; 2017 Nov; 47(11):1374-1382. PubMed ID: 28658564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of peripheral blood eosinophil markers to predict severity of asthma.
    Casciano J; Krishnan JA; Small MB; Buck PO; Gopalan G; Li C; Kemp R; Dotiwala Z
    BMC Pulm Med; 2016 Jul; 16(1):109. PubMed ID: 27473851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
    Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID
    Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.
    Kostikas K; Brindicci C; Patalano F
    Curr Drug Targets; 2018; 19(16):1882-1896. PubMed ID: 29437007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with ≤2% and >2% blood eosinophils.
    Marks-Konczalik J; Costa M; Robertson J; McKie E; Yang S; Pascoe S
    Respir Med; 2015 Jul; 109(7):860-9. PubMed ID: 26033641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma.
    George L; Taylor AR; Esteve-Codina A; Soler Artigas M; Thun GA; Bates S; Pavlidis S; Wagers S; Boland A; Prasse A; Boschetto P; Parr DG; Nowinski A; Barta I; Hohlfeld J; Greulich T; van den Berge M; Hiemstra PS; Timens W; Hinks T; Wenzel S; Siddiqui S; Richardson M; Venge P; Heath S; Gut I; Tobin MD; Edwards L; Riley JH; Djukanovic R; Auffray C; De-Meulder B; Erik-Dahlen S; Adcock IM; Chung KF; Ziegler-Heitbrock L; Sterk PJ; Singh D; Brightling CE;
    Allergy; 2020 Feb; 75(2):370-380. PubMed ID: 31506971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.